Financhill
Back

Syros Pharmaceuticals Quote, Financials, Valuation and Earnings

Buy
61

SYRS
Syros Pharmaceuticals

Last Price:
5.10
Seasonality Move:
18.1%

7 Day Trial

ALL ACCESS PASS

$ 7

Syros Pharmaceuticals Price Quote

$5.10
-0.01 (2%)
(Updated: June 1, 2024 at 6:37 AM ET)

Syros Pharmaceuticals Key Stats

Buy
61
Syros Pharmaceuticals (SYRS) is a Buy

Day range:
$4.82 - $5.13
52-week range:
$2.09 - $8.17
Dividend yield:
0%
P/E ratio:
0.00
P/S ratio:
16.00
P/B ratio:
9.07%

Volume:
135.7K
Avg. volume:
125.1K
1-year change:
32.73%
Market cap:
$136.6M
Revenue:
$9.9M
EPS:
$-5.05

How Much Does Syros Pharmaceuticals Make?

Data Unavailable

Is Syros Pharmaceuticals Growing As A Company?

Data Unavailable

Syros Pharmaceuticals Stock Price Performance

What Is Syros Pharmaceuticals 52-Week High & Low?

Syros Pharmaceuticals Price To Free Cash Flow

Data Unavailable

Is It Risky To Buy Syros Pharmaceuticals?

Is Syros Pharmaceuticals Cash Flow Positive?

  • What Is SYRS Cash Flow From Operations?
    Cash flow from operations (TTM) is -$103.9M
  • What Is Syros Pharmaceuticals’s Cash Flow From Financing?
    Cash flow from financing (TTM) is $43.3M
  • What Is Syros Pharmaceuticals’s Cash Flow From Investing?
    Cash flow from investing (TTM) is $38.4M

Syros Pharmaceuticals Return On Invested Capital

Data Unavailable

Syros Pharmaceuticals Earnings Date & Stock Price

Syros Pharmaceuticals Competitors

Syros Pharmaceuticals Dividend Yield

Data Unavailable

Syros Pharmaceuticals Analyst Estimates

YoY Growth Past Surprise
EPS: 0% 89.33%
Revenue: 0% -100%

Analyst Recommendations

Buy Recommendations: 2
Hold Recommendations: 0
Sell Recommendations: 0
Price Target: 19.25
Upside from Last Price: 276.71%

Major Shareholders

  • How many SYRS shares are owned by institutional investors?
    24M SYRS shares are owned by institutional investors
  • How many SYRS shares are owned by insiders?
    697.4K SYRS shares are owned by insiders